Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The Nitazene Control Act permanently adds a class of powerful synthetic opioids called nitazenes to Schedule I of the Controlled Substances Act, making them illegal with no accepted medical use. Nitazenes, which include compounds like etonitazene and isotonitazene that can be more potent than fentanyl, have increasingly appeared in the illicit drug supply and contributed to overdose deaths across the United States. The bill uses a broad chemical definition to classify the entire nitazene class and all similar analogs at once, allowing the government to address new variants without waiting for individual scheduling decisions. The legislation includes a limited exemption for researchers already conducting FDA or DEA-approved studies, allowing them 18 months to obtain proper registration while continuing their work. The bill was introduced in August 2025 and referred to the House Committees on Energy and Commerce and the Judiciary for consideration.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.